epithelial ovarian cancer

You have access
Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study
ANGIOLO GADDUCCI, STEFANIA COSIO, FABIO LANDONI, ANDREA ALBERTO LISSONI, PAOLO ZOLA, MARIA ELENA LAUDANI, ANTONIO ARDIZZOIA, ANGELA GAMBINO and ENRICO SARTORI

Anticancer Research April 2022, 42 (4) 2017-2022; DOI: https://doi.org/10.21873/anticanres.15681
You have access
Real-world Experience of Niraparib in Newly-diagnosed Epithelial Ovarian Cancer
WONKYO SHIN, JOSEPH J. NOH, SEUNG HUN BAEK, BYOUNG-GIE KIM, MYONG CHEOL LIM and SANG-YOON PARK

Anticancer Research September 2021, 41 (9) 4603-4607; DOI: https://doi.org/10.21873/anticanres.15273
Open Access
Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study
ANGIOLO GADDUCCI, ENRICO SIMONETTI, FEDERICA GUIDOCCIO, GIANPIERO MANCA, ASSUERO GIORGETTI, TOMMASO DEPALO, STEFANIA COSIO, MARIO MICCOLI and DUCCIO VOLTERRANI

Anticancer Research April 2021, 41 (4) 1937-1944; DOI: https://doi.org/10.21873/anticanres.14960
You have access
Positron Emission Tomography/Computed Tomography in Platinum-sensitive Recurrent Ovarian Cancer: A Single-center Italian Study
ANGIOLO GADDUCCI, ENRICO SIMONETTI, GIANPIERO MANCA, FEDERICA GUIDOCCIO, ANTONIO FANUCCHI, STEFANIA COSIO and DUCCIO VOLTERRANI

Anticancer Research April 2020, 40 (4) 2191-2197; DOI: https://doi.org/10.21873/anticanres.14180
You have access
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study
ANGIOLO GADDUCCI, STEFANIA COSIO, ANDREA ALBERTO LISSONI, VALENTINA ZIZIOLI, MARCO ADORNI, ANNA MARIA FERRERO, FABIO LANDONI and ENRICO SARTORI

Anticancer Research March 2020, 40 (3) 1543-1550; DOI: https://doi.org/10.21873/anticanres.14100
You have access
Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer
MARIA V. CHRISTENSEN, CLAUS HØGDALL, STEFFEN G. JENSEN, NOOR LOKMAN, CARMELA RICCIARDELLI, IB J. CHRISTENSEN, PERNILLE CHRISTIANSEN, JULIE BRASK, MONA A. KARLSEN, THERESE K. NISSEN, KIRSTEN M. JOCHUMSEN and ESTRID HØGDALL

Anticancer Research May 2019, 39 (5) 2475-2482; DOI: https://doi.org/10.21873/anticanres.13367
You have access
Diagnostic Power of Selected Cytokines, MMPs and TIMPs in Ovarian Cancer Patients – ROC Analysis
GRAŻYNA EWA BĘDKOWSKA, BARBARA PISKÓR, EWA GACUTA, MONIKA ZAJKOWSKA, JOANNA OSADA, MACIEJ SZMITKOWSKI, MILENA DĄBROWSKA and SŁAWOMIR ŁAWICKI

Anticancer Research May 2019, 39 (5) 2575-2582; DOI: https://doi.org/10.21873/anticanres.13380
You have access
Assessment of the Applicability of Integrative Tumor Response Assays in Advanced Epithelial Ovarian Cancer
JU-HYUN KIM, YONG SIK YOON, JIN CHEON KIM and YONG-MAN KIM

Anticancer Research January 2019, 39 (1) 313-318; DOI: https://doi.org/10.21873/anticanres.13113
You have access
Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5’ and 3’ Exons
KYUNG JIN EOH, HYUNG SEOK PARK, JI SOO PARK, SEUNG-TAE LEE, JUNG WOO HAN, JUNG-YUN LEE, SUNGHOON KIM, SANG WUN KIM, YOUNG TAE KIM and EUN JI NAM

Anticancer Research December 2018, 38 (12) 6947-6953; DOI: https://doi.org/10.21873/anticanres.13073
You have access
Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer
SIMON DUCOULOMBIER, FRANÇOIS GOLFIER, OLIVIER COLOMBAN, DAVID BENAYOUN, PIERRE-ADRIEN BOLZE, MICHEL TOD and BENOIT YOU

Anticancer Research December 2017, 37 (12) 6879-6886;

Main menu

User menu

Search

epithelial ovarian cancer

Pages